Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S (2020) Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci Total Environ 730:138996
Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Allen C, Arjona S, Santerre M (2020) Potential use of RNA-dependent RNA polymerase (RdRp) inhibitor against COVID-19 infection. All Life 13:608–614
Article
CAS
Google Scholar
Ashour HM, Elkhatib WF, Rahman M, Elshabrawy HA (2020) Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens 9(3):186
Article
CAS
PubMed Central
Google Scholar
Bansal P, Bingemann TA, Greenhawt M, Mosnaim G, Nanda A, Oppenheimer J, Sharma H, Stukus D, Shaker M (2020) Clinician wellness during the COVID-19 pandemic: extraordinary times and unusual challenges for the allergist/immunologist. J Allergy Clin Immunol Pract 8:1781–1790
Article
PubMed
PubMed Central
Google Scholar
Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP (2020) Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Investig 130:2757–2765
Article
CAS
PubMed
PubMed Central
Google Scholar
Brown K, Wang RC (2020) Politics and science: the case of china and the coronavirus. Asian Affairs 51:1–18
Article
Google Scholar
Cai Y, Yin D, Ling S, Tian X, Li Y, Xu Z, Jiang H, Zhang X, Wang X, Shi Y (2020) A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities. bioRxiv
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M (2020) A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). In: Statpearls [internet]. StatPearls Publishing
Chandel V, Raj S, Rathi B, Kumar D (2020) In silico identification of potent COVID-19 main protease inhibitors from FDA approved antiviral compounds and active phytochemicals through molecular docking: a drug repurposing approach
Channappanavar R, Perlman S (2017) Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. In: Seminars in immunopathology, vol 5. Springer, pp 529–539
Chaudhary NK, Chaudhary N, Dahal M, Guragain B, Rai S, Chaudhary R, Sachin K, Lamichhane-Khadka R, Bhattarai A (2020) Fighting the SARS CoV-2 (COVID-19) pandemic with soap
Chen L, Xiong J, Bao L, Shi Y (2020) Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20(4):398–400
Article
CAS
PubMed
PubMed Central
Google Scholar
Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135:2033–2040
Article
CAS
PubMed
Google Scholar
Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M (2020) The Cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev 53:25–32
Article
CAS
PubMed
PubMed Central
Google Scholar
Dariya B, Nagaraju GP (2020) Understanding novel COVID-19: its impact on organ failure and risk assessment for diabetic and cancer patients. Cytokine Growth Factor Rev 53:43–52
Article
CAS
PubMed
PubMed Central
Google Scholar
Daughton CG (2020) Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19. Glob Epidemiol 2:100026
Article
PubMed
PubMed Central
Google Scholar
Devaux CA, Rolain J-M, Colson P, Raoult D (2020) New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents 55:105938
Article
CAS
PubMed
PubMed Central
Google Scholar
Dong L, Hu S, Gao J (2020) Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Therap 14(1):58–60
Article
CAS
Google Scholar
Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J (2020) Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 75(18):2352–2371
Article
CAS
PubMed
PubMed Central
Google Scholar
Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y (2020) Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci 117(17):9490–9496
Article
CAS
PubMed
PubMed Central
Google Scholar
Felsenstein S, Herbert JA, McNamara PS, Hedrich CM (2020) COVID-19: immunology and treatment options. Clin Immunol 215:108448
Article
CAS
PubMed
PubMed Central
Google Scholar
Geng Y-J, Wei Z-Y, Qian H-Y, Huang J, Lodato R, Castriotta RJ (2020) Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol 47:107228
Article
CAS
PubMed
PubMed Central
Google Scholar
Ghias MH, Hyde MJ, Tomalin LE, Morgan BP, Alavi A, Lowes MA, Piguet V (2020) Role of the complement pathway in inflammatory skin diseases: a focus on hidradenitis suppurativa. J Investig Dermatol 140(3):531–536
Article
CAS
PubMed
Google Scholar
Gou W, Fu Y, Yue L, Chen G-d, Cai X, Shuai M, Xu F, Yi X, Chen H, Zhu YJ (2020) Gut microbiota may underlie the predisposition of healthy individuals to COVID-19. medRxiv
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure F-X (2020) Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med 382:2327–2336
Article
CAS
PubMed
Google Scholar
Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, Tan K-S, Wang D-Y, Yan Y (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res 7(1):1–10
CAS
Google Scholar
Hashimoto N, Kawabe T, Imaizumi K, Hara T, Okamoto M, Kojima K, Shimokata K, Hasegawa Y (2004) CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury. Am J Respir Cell Mol Biol 30(6):808–815
Article
CAS
PubMed
Google Scholar
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu J, Mo Y, Gao Z, Wang X, Gu M, Liang Y, Cheng X, Hu S, Liu W, Liu H (2016) PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice. Med Microbiol Immunol 205(4):381–395
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang J, Song W, Huang H, Sun Q (2020) Pharmacological therapeutics targeting rna-dependent rna polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19. J Clin Med 9(4):1131
Article
CAS
PubMed Central
Google Scholar
Hung IF-N, Lung K-C, Tso EY-K, Liu R, Chung TW-H, Chu M-Y, Ng Y-Y, Lo J, Chan J, Tam AR (2020) Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. The Lancet 395:1695–1704
Article
CAS
Google Scholar
Jalava K (2020) First respiratory transmitted food borne outbreak? Int J Hyg Environ Health 226:113490
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y, Li J, Du L, Jiang S, Guo R (2018) Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg Microbes Infect 7(1):1–12
Google Scholar
Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, Fang C, Huang D, Huang L-Q, Huang Q (2020a) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 7(1):4
CAS
PubMed
PubMed Central
Google Scholar
Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G (2020b) Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 12(4):372
Article
CAS
PubMed Central
Google Scholar
Khalili JS, Zhu H, Mak NSA, Yan Y, Zhu Y (2020) Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. J Med Virol 92:740–746
Article
CAS
PubMed
Google Scholar
Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, Bashir N, Xue M (2020) Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options. J Clin Microbiol 58(5):e00187-20
Article
PubMed
PubMed Central
Google Scholar
Kim J-M, Chung Y-S, Jo HJ, Lee N-J, Kim MS, Woo SH, Park S, Kim JW, Kim HM, Han M-G (2020) Identification of coronavirus isolated from a patient in Korea with COVID-19. Osong Public Health Res Perspect 11(1):3
Article
PubMed
PubMed Central
Google Scholar
Kulasekararaj AG, Hill A, Rottinghaus ST, Langemeijer S, Wells R, Gonzalez-Fernandez FA, Gaya A, Lee JW, Gutierrez EO, Piatek CI (2019) Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study. Blood 133(6):540–549
Article
CAS
PubMed
PubMed Central
Google Scholar
Kumar M, Taki K, Gahlot R, Sharma A, Dhangar K (2020) A chronicle of SARS-CoV-2: part-I-epidemiology, diagnosis, prognosis, transmission and treatment. Sci Total Environ 734:139278
Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55:105924
Article
CAS
PubMed
PubMed Central
Google Scholar
Le TT, Andreadakis Z, Kumar A, Roman RG, Tollefsen S, Saville M, Mayhew S (2020) The COVID-19 vaccine development landscape. Nat Rev Drug Discov 19:305–306
Article
CAS
Google Scholar
Lee JW, Sicre de Fontbrune F, Wong Lee Lee L, Pessoa V, Gualandro S, Füreder W, Ptushkin V, Rottinghaus ST, Volles L, Shafner L (2019) Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood 133(6):530–539
Article
CAS
PubMed
PubMed Central
Google Scholar
Lega S, Naviglio S, Volpi S, Tommasini A (2020) Recent Insight into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19. Vaccines 8(2):224
Article
CAS
PubMed Central
Google Scholar
Li J, Ma Q, Liu H, Song X, Pang Y, Su P, Sun F, Gou M, Lu J, Shan Y (2020a) Complement component C1q plays a critical role in VLRA/VLRC-mediated immune response. Dev Comp Immunol 111:103750
Article
CAS
PubMed
Google Scholar
Li X, Geng M, Peng Y, Meng L, Lu S (2020b) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharmaceut Anal 10:102–108
Google Scholar
Lim J, Jeon S, Shin H-Y, Kim MJ, Seong YM, Lee WJ, Choe K-W, Kang YM, Lee B, Park S-J (2020) Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 35(6):e79–e79
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, Smoot J, Gregg AC, Daniels AD, Jervey S (2020a) Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Publications
Liu K, Fang Y-Y, Deng Y, Liu W, Wang M-F, Ma J-P, Xiao W, Wang Y-N, Zhong M-H, Li C-H (2020b) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J 133:1025
Article
PubMed
PubMed Central
Google Scholar
Ludwig C, Wagner R (2007) Virus-like particles—universal molecular toolboxes. Curr Opin Biotechnol 18(6):537–545
Article
CAS
PubMed
Google Scholar
Lythgoe MP, Middleton P (2020) Ongoing clinical trials for the management of the COVID-19 pandemic. Trends Pharmacol Sci 41:363–382
Article
CAS
PubMed
PubMed Central
Google Scholar
Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 220:1–13
Article
CAS
PubMed
PubMed Central
Google Scholar
Malik YS, Kumar N, Sircar S, Kaushik R, Bhatt S, Dhama K, Gupta P, Goyal K, Singh MP, Ghoshal U (2020) Pandemic coronavirus disease (COVID-19): challenges and a global perspective
Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC, Huber-Lang M, Piemontese S, Assanelli A, Garlanda C (2020) The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol 215:108450
Article
CAS
PubMed
PubMed Central
Google Scholar
Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Heumatol 39:1–8
Google Scholar
Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron L, Pagliaro P, Pasqua T, Penna C, Rocca C, Samaja M (2020) COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. GeroScience 42:1–29
Article
CAS
Google Scholar
Nandy A (2019) COVID-19: an enigma which has engulfed the world
Neurath MF (2020) Covid-19 and immunomodulation in IBD. Gut 69:1335–1342
Article
CAS
PubMed
Google Scholar
Noris M, Benigni A, Remuzzi G (2020) The case of Complement activation in COVID-19 multiorgan impact. Kidney Int 98:314–322
Article
CAS
PubMed
PubMed Central
Google Scholar
Pal M, Berhanu G, Desalegn C, Kandi V (2020) Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus 12(3)
Paudel S, Dangal G, Chalise A, Bhandari TR, Dangal O (2020) The coronavirus pandemic: what does the evidence show? J Nepal Health Res Counc 18(2):1–9
Article
PubMed
Google Scholar
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W, Haque U (2020) The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 49:717–726
Article
PubMed
Google Scholar
Pillaiyar T, Meenakshisundaram S, Manickam M (2020) Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov Today 25:668–688
Article
CAS
PubMed
PubMed Central
Google Scholar
Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S (2020) Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Countries 14(02):125–128
Article
CAS
Google Scholar
Prompetchara E, Ketloy C, Palaga T (2020) Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38(1):1–9
CAS
PubMed
Google Scholar
Puneet P, Moochhala S, Bhatia M (2005) Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 288(1):L3–L15
Article
CAS
PubMed
PubMed Central
Google Scholar
Rajaei S, Dabbagh A (2020) The immunologic basis of COVID-19: a clinical approach. J Cell Mol Anesth 5(1):37–42
Google Scholar
Repici A, Maselli R, Colombo M, Gabbiadini R, Spadaccini M, Anderloni A, Carrara S, Fugazza A, Di Leo M, Galtieri PA (2020) Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest Endosc 92:192–197
Article
PubMed
PubMed Central
Google Scholar
Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet (London, England) 395(10223):e30
Article
CAS
Google Scholar
Rogosnitzky M, Okediji P, Koman I (2020) Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M (2020) Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. ecancermedicalscience 14
Safdar M, Yasmin M (2020) COVID‐19: a threat to educated Muslim women's negotiated identity in Pakistan. Gender, Work & Organization
Sehailia M (2020) In-silico studies of antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19
Sen S, Antara N, Sen S, Chowdhury S (2020) The Unprecedented pandemic 'COVID-19' effect on the Bangladesh apparel workers by shivering the apparel supply chain. Available at SSRN 3598542
Shafiq M, Qurashi F, Mushtaq S, Hussain M, Hameed A, Haider MS (2020) DNA plant viruses: biochemistry, replication, and molecular genetics. In: Applied plant virology. Elsevier, pp 169–182
Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L (2020) Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 323(16):1582–1589
Article
CAS
PubMed
PubMed Central
Google Scholar
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 24:91–98
Article
CAS
PubMed
PubMed Central
Google Scholar
Shetty R, Ghosh A, Honavar SG, Khamar P, Sethu S (2020) Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: present and future. Indian J Ophthalmol 68(5):693
Article
PubMed
PubMed Central
Google Scholar
Shi Y, Wang N, Zou Q (2020) Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV). Zhonghua Yu Fang Yi Xue Za Zhi [chin J Prevent Med] 54:E029–E029
Google Scholar
Singhal T (2020) A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 87:1–6
Article
Google Scholar
Smit C, Peeters MY, van den Anker JN, Knibbe CA (2020) Chloroquine for SARS-CoV-2: implications of its unique pharmacokinetic and safety properties. Clin Pharmacokinet 59:1
Article
CAS
Google Scholar
Smole U, Kratzer B, Pickl WF (2020) Soluble pattern recognition molecules: guardians and regulators of homeostasis at airway mucosal surfaces. Eur J Immunol 50(5):624–642
Article
CAS
PubMed
PubMed Central
Google Scholar
Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C (2019) From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses 11(1):59
Article
CAS
PubMed Central
Google Scholar
South AM, Diz DI, Chappell MC (2020) COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circul Physiol 318(5):H1084–H1090
Article
CAS
Google Scholar
Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LF (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20:1–12
Article
CAS
Google Scholar
To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC, Yip CC-Y, Cai J-P, Chan JM-C, Chik TS-H (2020) Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 20:565–574
Article
CAS
PubMed
PubMed Central
Google Scholar
Van Bavel JJ, Baicker K, Boggio PS, Capraro V, Cichocka A, Cikara M, Crockett MJ, Crum AJ, Douglas KM, Druckman JN (2020) Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav 4:1–12
Article
Google Scholar
Vennema H, Godeke G-J, Rossen J, Voorhout W, Horzinek M, Opstelten D, Rottier P (1996) Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J 15(8):2020–2028
Article
CAS
PubMed
PubMed Central
Google Scholar
Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 94(7):e00127-20
Article
PubMed
PubMed Central
Google Scholar
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q (2020) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet 395:1569–1578
Article
CAS
Google Scholar
Wilder-Smith A, Chiew CJ, Lee VJ (2020) Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis 20:e102–e107
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X (2020a) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 10:766–788
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu P, Hao X, Lau EH, Wong JY, Leung KS, Wu JT, Cowling BJ, Leung GM (2020b) Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Eurosurveillance 25(3):2000044
Article
PubMed Central
Google Scholar
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020c) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18–22
Article
CAS
PubMed
PubMed Central
Google Scholar
Xiang M, Fan J (2010) Pattern recognition receptor-dependent mechanisms of acute lung injury. Mol Med 16(1–2):69–82
Article
CAS
PubMed
Google Scholar
Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, Sun J, Chang C (2020) The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun 109:102434
Article
CAS
PubMed
PubMed Central
Google Scholar
Yi Y, Lagniton PN, Ye S, Li E, Xu R-H (2020) COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci 16(10):1753
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y (2020) The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 55:105955
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020a) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46:1–5
Article
Google Scholar
Zhang J, Zeng H, Gu J, Li H, Zheng L, Zou Q (2020b) Progress and prospects on vaccine development against SARS-CoV-2. Vaccines 8(2):153
Article
CAS
PubMed Central
Google Scholar
Zhang L, Liu Y (2020) Potential interventions for novel coronavirus in China: a systematic review. J Med Virol 92(5):479–490
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ (2020c) COVID-19: melatonin as a potential adjuvant treatment. Life Sci 250:117583
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou H, Hara H, Cooper DK (2019) The complex functioning of the complement system in xenotransplantation. Xenotransplantation 26(4):e12517
Article
PubMed
PubMed Central
Google Scholar
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733
Article
CAS
PubMed
PubMed Central
Google Scholar